Drugs like Wegovy can be effective at treating fatty liver disease

CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans

Starting July 1, Caremark will prioritize Wegovy on its formulary, making the weekly injection more accessible to its members.

Weight loss drug Wegovy can cure serious liver disease

A recent clinical trial reveals that Wegovy, a popular weight-loss drug containing semaglutide, shows promising results in treating liver diseases like MASH. The study, published in the New England Journal of Medicine, involved over 800 participants across 37 countries. Wegovy significantly reduced liver inflammation and scarring, offering hope for millions affected by fatty liver diseases.

Drugs like Wegovy can be effective at treating fatty liver disease

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic dysfunction-associated steatohepatitis (MASH)

Ozempic and Wegovy ingredient may reverse signs of liver disease

The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.

Exclusive | Ozempic, Wegovy took my vision, say grandma of 11 and NJ man — as more users report ‘devastating’ side effect

A grandma of 11 and a New Jersey man have joined the growing chorus of users of the wildly popular weight-loss drugs Ozempic and Wegovy who say they didn’t just lose fat — they also lost their eyesight.